| 1 |
Demonstrating beta-Glucan and Yeast Peptide Clearance in Biopharmaceutical Downstream Processes (vol 27, pg 442, 2011)
Jiang CP, Scherfner S, Dick LW, Mahon D, Qiu DF, Cheng KC, Shukla AA
Biotechnology Progress, 27(4), 1195, 2011 |
| 2 |
Isomerization in the CDR2 of a Monoclonal Antibody: Binding Analysis and Factors That Influence the Isomerization Rate
Dick LW, Qiu DF, Wong RB, Cheng KC
Biotechnology and Bioengineering, 105(3), 515, 2010 |
| 3 |
Investigation of Proteins and Peptides from Yeastolate and Subsequent Impurity Testing of Drug Product
Dick LW, Kakaley JA, Mahon D, Qiu DF, Cheng KC
Biotechnology Progress, 25(2), 570, 2009 |
| 4 |
C-terminal lysine variants in fully human monoclonal antibodies: Investigation of test methods and possible causes
Dick LW, Qiu DF, Mahon D, Adamo M, Cheng KC
Biotechnology and Bioengineering, 100(6), 1132, 2008 |
| 5 |
Determination of the origin of the N-terminal pyro-glutamate variation in monoclonal antibodies using model peptides
Dick LW, Kim C, Qiu DF, Cheng KC
Biotechnology and Bioengineering, 97(3), 544, 2007 |
